The patient voice in clinical trial research Canadian Cancer Trials Group (CCTG) recognizes the value and importance of engaging patients, including the patient voice in all aspects of the clinical trial life-cycle. Integrating the patient perspective into the CCTG’s overall strategic agenda ensures the research agenda has the greatest impact on cancer patients in Canada and around the world. CCTG has implemented a model of dedicated public and patient involvement by including the Patient Representative, who are patient volunteers recruited to disease site committees similar to academic committee members with a three year extendable term. The role of the CCTG Patient Representative has evolved to integrate the patient perspective into many steps of the research process with the aim of: research questions that matter to patients, and improved accrual CCTG is committed to implementing best practices and materials to foster and facilitate patient engagement CCTG Patient Representatives Judy Needham - Patient Representative Chair Bob Taylor Carol Gordon David McMullen Erwin Wanderer Janice Hodgson Joan Petrie Lynne Bezanson Marie-Térèse Little Martina Wood Patrick Sullivan Richard Wassersug Marg Redlick Bill Richardson Sylvie Desmarais Louise Bird Hilary Horlock
